The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Grange David L since 2006.
The trader's CIK number is 1264908.
At the time of the last reporting, Grange David L was the Director of Pharmaceutical Product Development Inc. (stock ticker symbol PPDI).
Also see all insider trading activities at Pharmaceutical Product Development Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | PPDI | 0 | $0 | 34,501 | $897,026 | 34,501 | $705,545 |
| 2010 | PPDI | 0 | $0 | 51,753 | $1,330,677 | 51,753 | $1,137,530 |
| 2008 | PPDI | 0 | $0 | 20,198 | $835,186 | 20,198 | $698,850 |
| 2007 | PPDI | 0 | $0 | 11,458 | $389,132 | 11,458 | $220,205 |
| 2006 | PPDI | 0 | $0 | 10,000 | $362,400 | 10,000 | $150,600 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-02-28 | PPDI | Sale | 34,501 | 26.00 | 897,026 |
| 2011-02-28 | PPDI | Option Ex | 34,501 | 20.45 | 705,545 |
| 2010-11-02 | PPDI | Option Ex | 373 | 21.98 | 8,198 |
| 2010-11-03 | PPDI | Option Ex | 51,380 | 21.98 | 1,129,332 |
| 2010-11-02 | PPDI | Sale | 373 | 26.00 | 9,698 |
| 2010-11-03 | PPDI | Sale | 51,380 | 25.71 | 1,320,979 |
| 2008-08-07 | PPDI | Option Ex | 10,099 | 34.60 | 349,425 |
| 2008-08-07 | PPDI | Sale | 10,099 | 41.35 | 417,593 |
| 2008-08-07 | PPDI | Option Ex | 10,099 | 34.60 | 349,425 |
| 2008-08-07 | PPDI | Sale | 10,099 | 41.35 | 417,593 |
| 2007-07-26 | PPDI | Option Ex | 5,458 | 23.79 | 129,845 |
| 2007-07-26 | PPDI | Sale | 5,458 | 33.76 | 184,262 |
| 2007-02-09 | PPDI | Sale | 6,000 | 34.15 | 204,870 |
| 2007-02-09 | PPDI | Option Ex | 6,000 | 15.06 | 90,360 |
| 2006-05-24 | PPDI | Option Ex | 10,000 | 15.06 | 150,600 |
| 2006-05-24 | PPDI | Sale | 10,000 | 36.24 | 362,400 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Grange David L (Director of Pharmaceutical Product Development Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.